Author/Authors :
Sampaio، نويسنده , , Roney O. and Grinberg، نويسنده , , Max and Leite، نويسنده , , Joمo J. and Tarasoutchi، نويسنده , , Flلvio and Chalela، نويسنده , , William A. and Izaki، نويسنده , , Marisa and Spina، نويسنده , , Guilherme S. and Rossi، نويسنده , , Eduardo Giusti and Mady، نويسنده , , Charles، نويسنده ,
Abstract :
The effects of 12 months of therapy were evaluated in 47 mildly symptomatic patients with moderate to severe mitral valve regurgitation; 26 patients received enalapril and 21 received a placebo. Enalapril was associated with a significant reduction in left ventricular diameter and mitral regurgitation volume, with no evidence of change in systolic function indexes. However, enalapril did not hinder progressive aerobic impairment to effort.
